In 2023, the average length of stay for patients with malignant neoplasm of the trachea, bronchus, and lung in Italy stood at 10.2 days. Forecasts from 2024 to 2028 indicate stability with a slight decrease to 10.1 days by 2028. Year-on-year variation remains minimal, with a negligible change emphasizing a consistent average. The compound annual growth rate over the five-year forecast does not suggest significant shifts.
Future trends to watch for include advancements in medical technology and treatment protocols, potentially reducing hospitalization durations. Additionally, healthcare policy changes and demographic shifts could influence these metrics.
